Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,215.00    155.00 (3.06%)
Bid:
5,205.00
Ask:
5,215.00
Spread: 10.00 (0.192%)
Market Cap: £3.79b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

9 May 2018 07:00

RNS Number : 4154N
Renishaw PLC
09 May 2018
 

Renishaw plc

Trading update

9th May 2018

Ahead of the investor day being held tomorrow, we are providing a trading update as follows:

 

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the nine months ended 31st March 2018. It contains unaudited information that covers the first three quarters and the period since.

 

Trading activity

 

Continuing operations

9 months to 31st March 2018

9 months to 31st March 2017*

Change

Metrology

£406.6m

£361.4m

+12.5%

Healthcare

£23.3m

£22.9m

+1.7%

Total Revenue

£429.9m

£384.3m

+11.9%

 

 

 

 

Adjusted* Profit before tax

£97.6m

£70.1m

+39.2%

Statutory Profit before tax

£104.4m

£69.7m

+49.8%

 

 

Revenue from continuing operations for the first three quarters of the current financial year was £429.9m, an increase of 11.9% compared with £384.3m for the corresponding period last year. We experienced underlying growth at constant exchange rates of 16.4%, with growth in all regions.

 

In our metrology business revenue amounted to £406.6m compared with £361.4m for the same period last year, with an underlying growth at constant exchange rates of 16.9%. Revenue in our healthcare business was £23.3m compared with £22.9m for the same period last year, an increase of 5.9% at constant exchange rates.

 

Adjusted* profit before tax from continuing operations for the first three quarters amounted to £97.6m compared with a restated adjusted* profit before tax of £70.1m for the corresponding period last year.

 

Financial position 

The Group balance sheet remains strong with net cash balances of £91.2m as at 31st March 2018 (30th June 2017: £51.9m).

 

Outlook

Notwithstanding current economic uncertainties, the Board remains confident in the future prospects of the Group. In our half year interim report, we forecast full year revenue to be in the range of £575m to £605m and adjusted profit before tax to be in the range of £127m to £147m. We continue to expect growth in both revenue and profit for this financial year and now expect full year revenue to be in the range of £585m to £610m and adjusted profit before tax to be in the range of £135m to £150m. Statutory profit before tax is expected to be in the range of £145m to £160m.

The preliminary full year results for the year ending 30th June 2018 will be released on 26th July 2018.

 

 

Sir David McMurtry William Lee

CBE, RDI, FRS, FREng, CEng, FIMechE Chief Executive Officer

Executive Chairman

 

9th May 2018

 

 

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

LEI number 21380048ADXM6Z67CT18

Telephone number 01453 524524

Website www.renishaw.com 

 

 

* Adjusted profit before tax and prior year restatements

 

In the trading update issued on 10th May 2017, the cumulative profit before tax for the first three quarters of the financial year 2017 was reported as £69.3m. The results of the spatial measurement business have been excluded as this business has been reclassified as a discontinued activity, giving rise to an increase in profit before tax of £0.8m.

 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IAS39 'Financial Instruments: Recognition and Measurement'. The board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

 

£'m

9 months to 31st March 2018

 

9 months to 31st March 2017

 

 

 

 

Profit before tax as previously reported

 

 

69.3

 

 

 

 

Restatement for discontinued operations

 

 

0.8

 

 

 

 

Restated adjusted profit before tax from continuing operations

97.6

 

70.1

 

 

 

 

Fair value gains/losses on financial instruments not eligible for hedge accounting

 

 

 

- reported in revenue

2.6

 

7.9

- reported in losses from the fair value of financial instruments

4.2

 

 (8.3)

 

 

 

 

Restated statutory profit before tax from continuing operations

104.4

 

69.7

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASSPESAPEFF
Date   Source Headline
24th Sep 20207:00 amRNSDirectors' Remuneration Policy – Clarification
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.